Table 1.
Characteristics of the study subjects in the robust, dynapenia, presarcopenia, and sarcopenia groups.
Characteristics of the study participants | Groups | |||||
---|---|---|---|---|---|---|
Robust | Dynapenia | Pre-sarcopenia | Sarcopenia | Total | P value | |
n = 74 | n = 28 | n = 17 | n = 14 | n = 133 | ||
Continuous variables | ||||||
Age (years), mean (SD) | 70.20 (3.84) | 72.71 (4.53) | 69.65 (2.84) | 73.57 (5.00) | 71.01 (4.14) | 0.208 |
BMI (kg/m2), mean (SD) | 25.03 (2.12) | 24.95 (2.19) | 20.500 (1.64) | 22.500 (2.01) | 24.17 (2.43) | 0.680 |
Abdominal circumference(cm) , mean (SD) | 82.15 (6.45) | 81.93 (6.37) | 71.29 (5.91) | 77.79 (6.50) | 80.26 (6.83) | 0.975 |
Systolic blood pressure (mmHg), mean (SD) | 136.64 (14.13) | 130.14 (13.65) | 124.47 (7.86) | 131.57 (12.57) | 133.18 (13.29) | 0.077 |
Diastolic blood pressure (mmHg), mean (SD) | 80.26 (9.14) | 75.79 (7.50) | 73.94 (8.08) | 76.36 (7.60) | 78.10 (8.60) | 0.650 |
Sleep (hour) , mean (SD) | 6.76 (0.89) | 6.45 (0.95) | 6.76 (0.84) | 6.50 (0.79) | 6.67 (0.89) | 0.841 |
Pulse (/min) , mean (SD) | 71.86 (7.14) | 73.82 (8.15) | 76.64 (9.00) | 70.71 (5.90) | 73.18 (8.02) | 0.325 |
Clinical indicators | ||||||
Gender (male), n (%) | 38 (51.35) | 10 (35.71) | 4 (23.53) | 2 (14.29) | 54 (40.60) | 0.019 |
Hypertension, n (%) | 11 (14.86) | 5 (17.86) | 2 (11.76) | 1 (7.14) | 19 (14.29) | 0.805 |
Type 2 diabetes mellitus, n (%) | 11 (10) | 5 (10.64) | 3 (12.5) | 1 (5) | 20 (9.95) | 0.976 |
Malignancy, n (%) | 5 (6.76) | 1 (3.57) | 2 (11.76) | 3 (21.43) | 11 (8.27) | 0.212 |
Coronary heart disease, n (%) | 4 (3.64) | 2 (4.26) | 1 (4.17) | 1 (5) | 8 (3.98) | 0.941 |
Chronic obstructive pulmonary disease, n (%) | 1 (1.35) | 1 (3.57) | 1 (5.88) | 2 (14.29) | 5 (3.76) | 0.128 |
Smoking, n (%) | 16 (21.62) | 3 (10.71) | 3 (17.65) | 2 (14.29) | 24 (18.05) | 0.616 |
Osteoporosis, n (%) | 5 (4.55) | 7 (14.89) | 3 (12.50) | 0 (0) | 15 (7.46) | 0.377 |
Differences were tested using one-way ANOVA.